Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Chartmill

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Intellicheck Inc (NASDAQ:IDN) Reports Record Revenue and Swings to Profit in Q1 ↗
Via Chartmill
Tickers IDN
TransAct Technologies (NASDAQ:TACT) Surges on Q1 Earnings Beat, Strong Casino Growth ↗
Via Chartmill
Topics Earnings
Tickers TACT
Fold Holdings Inc (NASDAQ:FLD) Misses Q1 Estimates, Shares Slip 6.8% After-Hours ↗
Via Chartmill
Tickers FLD
Fractyl Health Inc (NASDAQ:GUTS) Q1 Earnings: Net Income Swing Masks Core Operating Burn as Key Revita Data Readout Looms ↗
Via Chartmill
Tickers GUTS
Andersen Group Inc. (NYSE:ANDG) Q1 Results Beat Estimates, Stock Gains in After-Hours Trading ↗
Via Chartmill
Tickers ANDG
These stocks are moving in today's after hours session ↗
Via Chartmill
Tickers ADTX BE CAEP CGTL CPHI CREG
Nextpower (NASDAQ:NXT) Shares Surge After Earnings Beat and Raised Outlook ↗
Via Chartmill
Topics Earnings
Tickers NXT
Stereotaxis Inc (NYSEARCA:STXS) Slides 6% After Q1 Revenue Miss Despite Narrower-Than-Expected Loss ↗
Via Chartmill
Tickers STXS
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance ↗
Via Chartmill
Tickers TELA
Atea Pharmaceuticals (NASDAQ:AVIR) Q1 Loss Narrows as HCV and HEV Pipeline Catalysts Loom ↗
Via Chartmill
Tickers AVIR
Spectral AI Inc. (NASDAQ:MDAI) Reports Mixed Q1 2026 Results with Revenue and EPS Miss, But Reaffirms Annual Guidance ↗
Via Chartmill
Topics Artificial Intelligence
Tickers MDAI
Inhibikase Therapeutics Inc (NASDAQ:IKT) Reports Q1 2026 Results as Phase 3 PAH Trial Gains Momentum ↗
Via Chartmill
Tickers IKT
HireQuest Inc (NASDAQ:HQI) Q1 2026 Earnings Beat and 4.8% After-Hour Gain ↗
Via Chartmill
Topics Earnings
Tickers HQI
Arteris Inc (NASDAQ:AIP) Beats Q1 Estimates and Guides Higher Amid Accelerating AI Chip Demand ↗
Via Chartmill
Topics Artificial Intelligence
Tickers AIP
MaxCyte (NASDAQ:MXCT) Q1 2026 Results Beat Estimates, Stock Rises on Buyback ↗
Via Chartmill
Tickers MXCT
Lineage Cell Therapeutics (NYSEARCA:LCTX) Q1 2026 Results: Revenue Miss and Increased Losses Weigh on Investor Sentiment ↗
Via Chartmill
Tickers LCTX
NCMI Q1 Results In Line; Eyes $11M Cost Savings Amid Transformation ↗
Via Chartmill
Tickers NCMI
AudioEye Inc (NASDAQ:AEYE) Surges 26% After Massive Q1 Earnings Beat ↗
Via Chartmill
Tickers AEYE
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗
Via Chartmill
Tickers OPRX
Intelligent Protection Management Corp. (NASDAQ:IPM) Shares Rise on Q1 Results as Core Business Improves ↗
Via Chartmill
Tickers IPM
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Q1 2026 EPS Matches Estimates, Stock Flat ↗
Via Chartmill
Tickers ZNTL
QuickLogic (NASDAQ:QUIK) Shares Slide 15% After Q1 Miss on Revenue and Earnings ↗
Via Chartmill
Tickers QUIK
Resideo Technologies (REZI) Stock Slides 5% After Q1 Earnings Beat, Market Digests Details ↗
Via Chartmill
Topics Earnings
Tickers REZI
Capricor Therapeutics Inc (NASDAQ:CAPR) Q1 Results Show EPS Miss as Market Awaits August PDUFA Date ↗
Via Chartmill
Tickers CAPR
Kura Oncology (NASDAQ:KURA) Slips After Q1 Earnings Miss ↗
Via Chartmill
Tickers KURA
TriSalus Life Sciences (NASDAQ:TLSI) Swings to Surprise Net Profit in Q1, But Revenue Miss Tempers Outlook ↗
Via Chartmill
Tickers TLSI
BEACHBODY CO INC/THE (NASDAQ:BODI) Posts Third Consecutive Profitable Quarter as Revenue Continues to Shrink ↗
Via Chartmill
Tickers BODI
Evolv Technology (NASDAQ:EVLV) Q1 2026 Earnings Beat Driven by Subscription Growth ↗
Via Chartmill
Topics Earnings
Tickers EVLV
Nkarta (NASDAQ:NKTX) Q1 2026 Narrower Loss Beats Estimates as Autoimmune Trial Advances ↗
Via Chartmill
Tickers NKTX
Tenon Medical (NASDAQ:TNON) Q1 Revenue Surges 90% as Gross Margin Expands, Loss Narrows ↗
Via Chartmill
Tickers TNON
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.